VEGFA and breast cancer: HEXIM1 has also been known to have antiangiogenic effect by preventing estrogen-induced vascular endothelial growth factor (VEGF) transcription through inhibition of estrogen receptor-alpha recruitment to the VEGF promoter in MCF-7 breast cancer cells [25].